Influence of Selective Inhibition of Monoamine Oxidase A or B on Striatal Metabolism of l‐DOPA in Hemiparkinsonian Rats

@article{Finberg1995InfluenceOS,
  title={Influence of Selective Inhibition of Monoamine Oxidase A or B on Striatal Metabolism of l‐DOPA in Hemiparkinsonian Rats},
  author={John P.M. Finberg and J. Wang and David S. Goldstein and Irwin J. Kopin and K. S. Bankiewicz},
  journal={Journal of Neurochemistry},
  year={1995},
  volume={65}
}
Abstract: The effect of selective inhibition of monoamine oxidase (MAO) subtypes A and B on striatal metabolism of DOPA to dopamine (DA), 3,4‐dihydroxyphenylacetic acid (DOPAC), and 4‐hydroxy‐3‐methoxyphenylacetic acid (homovanillic acid; HVA) was studied in halothane‐anesthetized rats 3 weeks after unilateral 6‐hydroxydopamine lesion of the substantia nigra. Implantation of bilateral microdialysis probes allowed simultaneous quantitation of metabolite production on lesioned and control sides… 
Effect of Long‐Term Treatment with Selective Monoamine Oxidase A and B Inhibitors on Dopamine Release from Rat Striatum In Vivo
TLDR
DA metabolism was reduced only by clorgyline, whereas neuronal release of DA was enhanced by both MAO‐A andMAO‐B inhibitors on chronic administration, and the enhanced DA release does not appear to be dependent on production of amphetamine‐like metabolites of the inhibitor.
Increased L‐DOPA‐derived dopamine following selective MAO‐A or ‐B inhibition in rat striatum depleted of dopaminergic and serotonergic innervation
TLDR
This work sought to clarify the roles of MAO‐A andMAO‐B in deamination of DA formed from exogenous L‐DOPA in rat striatum depleted of dopaminergic, or both dopamine and serotonergic innervations.
Microdialysis study of the effects of the antiparkinsonian drug budipine on L‐DOPA‐induced release of dopamine and 5‐hydroxytryptamine by rat substantia nigra and corpus striatum
TLDR
It is concluded that budipine, at a therapeutically relevant dose, potentiates the release of dopamine newly synthesised from L‐DOPA from either end of the nigrostriatal dopamine axis.
Biochemical effects of the monoamine neurotoxins DSP‐4 and MDMA in specific brain regions of MAO‐B‐deficient mice
TLDR
The present findings suggest that MAO‐B is not involved in the mechanism of action of DSP‐4, whereas it plays opposite roles in MDMA‐induced DA and 5HT depletions.
Striatal Dopamine Metabolism in Monoamine Oxidase B‐Deficient Mice : A Brain Dialysis Study
TLDR
It is suggested that in mice, DA is only metabolized byMAO A under basal conditions and by both MAO A and B at high concentrations, in contrast to the rat, where DA is always metabolizing by MAO B regardless of concentration.
Increased striatal dopamine production from L-DOPA following selective inhibition of monoamine oxidase B by R(+)-N-propargyl-1-aminoindan (rasagiline) in the monkey.
Striatal extracellular fluid concentrations of dopamine and metabolites in response to direct striatal administration of two L-DOPA boluses administered sequentially were determined in three rhesus
The novel type B MAO inhibitor PF9601N enhances the duration of L-DOPA-induced contralateral turning in 6-hydroxydopamine lesioned rats
TLDR
The results suggest that PF9601N may be used as a novel tool in the treatment of Parkinson's disease by enhancing the duration of contralateral rotational behavior with respect to L-DOPA plus vehicle in a dose-related manner.
...
...

References

SHOWING 1-10 OF 55 REFERENCES
l‐3,4‐Dihydroxyphenylalanine‐Induced Dopamine Release in the Striatum of Intact and 6‐Hydroxydopamine‐Treated Rats: Differential Effects of Monoamine Oxidase A and B Inhibitors
TLDR
A model in which exogenous l‐DOPA elicits enhanced extracellular accumulation of dopamine in the dopamine‐depleted striatum is supported because some transmitter synthesis occurs at nondopaminergic sites and the dopamine terminals that normally take up and catabolize this pool of transmitter are absent.
Brain Dialysis: In Vivo Metabolism of Dopamine and Serotonin by Monoamine Oxidase A but Not B in the Striatum of Unrestrained Rats
TLDR
DA and 5‐HT in rat striatum may be preferentially deaminated by MAO‐A in vivo, and high‐dose treatment with clorgyline caused a significant decrease in levels of these three metabolites in both the perfusates and tissue homogenates.
Effects of Selective Monoamine Oxidase Inhibitors on the In Vivo Release and Metabolism of Dopamine in the Rat Striatum
TLDR
Brain microdialysis was used to examine the in vivo efflux and metabolism of dopamine (DA) in the rat striatum following monoamine oxidase (MAO) inhibition, and data suggest that DA metabolism is mediated principally by MAO‐A in theRat striatum.
Striatal L-dopa metabolism studied in vivo in rats with nigrostriatal lesions
TLDR
The results suggest that the striatum with a reduction in DA nerve terminals is deficient both in the capacity to synthesize DA and in the storage mechanisms necessary to protect the newly synthesized DA from oxidative metabolism.
Inhibition of monoamine oxidase-B by (-)-deprenyl potentiates neuronal responses to dopamine agonists but does not inhibit dopamine catabolism in the rat striatum.
TLDR
In electrophysiological studies, single caudate neuron responses to iontophoretically applied (-)-apomorphine and (+/-)-2-(N-phenethyl-N-propyl) amino-5-hydroxytetralin were potentiated by intracarotid injections of PE and i.p. injections of (-)-deprenyl.
Effect of selective and reversible MAO inhibitors on dopamine outflow in rat striatum: a microdialysis study.
TLDR
Reversible MAO-A inhibitors markedly increased the output of DA and concomitantly decreased theoutput of DOPAC and HVA, and these effects were absent with the highly selectiveMAO-B inhibitor Ro 19-6327.
The presence of the type A form of monoamine oxidase within nigrostriatal dopamine-containing neurons.
TLDR
The nigrostriatal dopaminergic pathway was selected as a model system to determine the form (i.e., type A or B) of monoamine oxidase (MAO) present within central dopamine (DA)-containing neurons of the rat brain, and results strongly indicate the presence of the type A form of MAO.
...
...